CBRN
As of 00:00 on Wednesday 20 June CEST, over 130 people are reported to have died in the Democratic Republic of the Congo and across the border in neighbouring Uganda in a new outbreak of the Ebola virus. According to information published by the United States Centers of Disease
Medical
SERB Pharmaceuticals, a global specialty pharmaceutical company focused on rare diseases and medical emergencies, has announced that their ThyroSafe potassium iodide (KI) tablets are now commercially available in the United States in a 130 mg dose. ThyroSafe tablets are designed to offer reliable thyroid blocking in the event of nuclear
CBRN
As of 1pm CEST on Wednesday 6 May, three people are confirmed to have died and three more have been evacuated from a cruise ship currently docked in Cape Verde amid a suspected outbreak of hantavirus. A total of eight cases have been confirmed by laboratory testing at the time
Medical
The World Health Organization (WHO) has handed over $44,800 USD worth of CBRN equipment and PPE to the Sri Lankan Ministry of Health. Announced on X on Friday 27 February, the package was received by the additional secretary of Medical Services Dr. Kumara Wickremasinghe; director general of Health Services,
Medical
Fifty-nine collective-protection filters arrived at Incirlik Air Base, southern Turkey, on 22 January. The shipment marks a major milestone in a $780,000 medical infrastructure upgrade designed to ensure uninterrupted care during CBRN contamination scenarios, according to a statement released by the US Air Force. "The delivery
Medical
The US Army and Bangladesh Armed Forces are to advance their medical partnership following a visit from US Army Major General E. Darrin Cox, commander of the 18th Theater Medical Command, to Bangladesh between 18-22 January, where he met with senior military and diplomatic officials. According to information released
Medical
The United Kingdom's Ministry of Defence has revealed that their Project Melorius, which had been intended to replace an in-service chemical and biological medical countermeasure capability, was scrapped in favour of an off-the-shelf, commercially available alternative. A sum of almost £12.6 million was subsequently